RNAi for Therapeutic Market - Global Professional Analysis and Forecast to 2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The worldwide RNAi for Therapeutic market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 8.2% during the forecast period.

    This report presents the market size and development trends by detailing the RNAi for Therapeutic market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the RNAi for Therapeutic market will be shown in this report. In short, this report will comprehensively reveal the characteristics of RNAi for Therapeutic industry and will help you to build a panoramic view of the industrial development.

    RNAi for Therapeutic Market, By Type:

    • siRNA

    • miRNA

    • shRNA

    RNAi for Therapeutic Market, By Application:

    • Cancer

    • Cardiovascular

    • HBV

    • Others

    Some of the leading players are as follows:

    • Mirna Therapeutics

    • Arrowhead

    • miRagen Therapeutics

    • Quark Pharmaceuticals

    • Dicerna Pharmaceuticals

    • Alnylam Pharmaceuticals

    • Gradalis

    • Sirnaomics

    • RXi Pharmaceuticals

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of RNAi for Therapeutic Market

    • 1.3 Market Segment by Type

      • 1.3.1 siRNA

      • 1.3.2 miRNA

      • 1.3.3 shRNA

    • 1.4 Market Segment by Application

      • 1.4.1 Cancer

      • 1.4.2 Cardiovascular

      • 1.4.3 HBV

      • 1.4.4 Others

    • 1.5 Market Segment by Regions

      • 1.5.1 North America RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 LAMEA RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of RNAi for Therapeutic Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of RNAi for Therapeutic by Major Types

      • 3.4.1 siRNA

      • 3.4.2 miRNA

      • 3.4.3 shRNA

    4 Segmentation of RNAi for Therapeutic Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of RNAi for Therapeutic by Major End-Users

      • 4.4.1 Cancer

      • 4.4.2 Cardiovascular

      • 4.4.3 HBV

      • 4.4.4 Others

    5 Market Analysis by Major Regions

    • 5.1 Global RNAi for Therapeutic Production Analysis by Top Regions

    • 5.2 Global RNAi for Therapeutic Consumption Analysis by Top Regions

    • 5.3 Global RNAi for Therapeutic Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America RNAi for Therapeutic Production, Import, Consumption and Export Analysis

      • 5.3.2 Europe RNAi for Therapeutic Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific RNAi for Therapeutic Production, Import, Consumption and Export Analysis

      • 5.3.4 LAMEA RNAi for Therapeutic Production, Import, Consumption and Export Analysis

    6 Product Circulation of RNAi for Therapeutic Market among Top Countries

    • 6.1 Top 5 Export Countries in RNAi for Therapeutic Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in RNAi for Therapeutic Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in RNAi for Therapeutic Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in RNAi for Therapeutic Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in RNAi for Therapeutic Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in RNAi for Therapeutic Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. North America RNAi for Therapeutic Landscape Analysis

    • 7.1 North America RNAi for Therapeutic Landscape Analysis by Top Countries

      • 7.1.1 United States RNAi for Therapeutic Market Volume and Growth Rate

      • 7.1.2 Canada RNAi for Therapeutic Market Volume and Growth Rate

      • 7.1.3 Mexico RNAi for Therapeutic Market Volume and Growth Rate

    8. Europe RNAi for Therapeutic Landscape Analysis

    • 8.1 Europe RNAi for Therapeutic Landscape Analysis by Major Types

    • 8.2 Europe RNAi for Therapeutic Landscape Analysis by Major End-Users

    • 8.3 Europe RNAi for Therapeutic Landscape Analysis by Top Countries

      • 8.3.1 Germany RNAi for Therapeutic Market Volume and Growth Rate

      • 8.3.2 UK RNAi for Therapeutic Market Volume and Growth Rate

      • 8.3.3 France RNAi for Therapeutic Market Volume and Growth Rate

      • 8.3.4 Italy RNAi for Therapeutic Market Volume and Growth Rate

      • 8.3.5 Spain RNAi for Therapeutic Market Volume and Growth Rate

      • 8.3.6 Belgium RNAi for Therapeutic Market Volume and Growth Rate

      • 8.3.7 Poland RNAi for Therapeutic Market Volume and Growth Rate

      • 8.3.8 Russia RNAi for Therapeutic Market Volume and Growth Rate

      • 8.3.9 Turkey RNAi for Therapeutic Market Volume and Growth Rate

      • 8.3.10 Netherlands RNAi for Therapeutic Market Volume and Growth Rate

      • 8.3.11 Portugal RNAi for Therapeutic Market Volume and Growth Rate

      • 8.3.12 Denmark RNAi for Therapeutic Market Volume and Growth Rate

      • 8.3.13 Finland RNAi for Therapeutic Market Volume and Growth Rate

      • 8.3.14 Iceland RNAi for Therapeutic Market Volume and Growth Rate

      • 8.3.15 Norway RNAi for Therapeutic Market Volume and Growth Rate

      • 8.3.16 Sweden RNAi for Therapeutic Market Volume and Growth Rate

    • 8.4 Top 3 Players Profiles in Europe

    9 Asia Pacific RNAi for Therapeutic Landscape Analysis

    • 9.1 Asia Pacific RNAi for Therapeutic Landscape Analysis by Top Countries

      • 9.1.1 China RNAi for Therapeutic Market Volume and Growth Rate

      • 9.1.2 Japan RNAi for Therapeutic Market Volume and Growth Rate

      • 9.1.3 Australia and New Zealand (ANZ) RNAi for Therapeutic Market Volume and Growth Rate

      • 9.1.4 India RNAi for Therapeutic Market Volume and Growth Rate

      • 9.1.5 ASEAN RNAi for Therapeutic Market Volume and Growth Rate

      • 9.1.6 South Korea RNAi for Therapeutic Market Volume and Growth Rate

    10 LAMEA RNAi for Therapeutic Landscape Analysis

    • 10.1 LAMEA RNAi for Therapeutic Landscape Analysis by Top Countries

      • 10.1.1 GCC Countries RNAi for Therapeutic Market Volume and Growth Rate

      • 10.1.2 Brazil RNAi for Therapeutic Market Volume and Growth Rate

      • 10.1.3 North Africa RNAi for Therapeutic Market Volume and Growth Rate

      • 10.1.4 South Africa RNAi for Therapeutic Market Volume and Growth Rate

      • 10.1.5 Argentina RNAi for Therapeutic Market Volume and Growth Rate

    11 Major Players Profiles

    • 11.1 Mirna Therapeutics

      • 11.1.1 Mirna Therapeutics Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Arrowhead

      • 11.2.1 Arrowhead Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 miRagen Therapeutics

      • 11.3.1 miRagen Therapeutics Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Quark Pharmaceuticals

      • 11.4.1 Quark Pharmaceuticals Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Dicerna Pharmaceuticals

      • 11.5.1 Dicerna Pharmaceuticals Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Alnylam Pharmaceuticals

      • 11.6.1 Alnylam Pharmaceuticals Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Gradalis

      • 11.7.1 Gradalis Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Sirnaomics

      • 11.8.1 Sirnaomics Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 RXi Pharmaceuticals

      • 11.9.1 RXi Pharmaceuticals Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 76 Figures and 204 Tables)

    • Figure Product Picture

    • Figure Market Size and Growth Rate of siRNA

    • Figure Market Size and Growth Rate of miRNA

    • Figure Market Size and Growth Rate of shRNA

    • Figure Market Size and Growth Rate of Cancer

    • Figure Market Size and Growth Rate of Cardiovascular

    • Figure Market Size and Growth Rate of HBV

    • Figure Market Size and Growth Rate of Others

    • Figure North America RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure United States RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure Canada RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure Europe RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure Germany RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure UK RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure France RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure Italy RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure Spain RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure Poland RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure Russia RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure China RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure Japan RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure Australia RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure India RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure LAMEA RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure GCC RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure North Africa RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of RNAi for Therapeutic Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of RNAi for Therapeutic

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of RNAi for Therapeutic by Different Types from 2014 to 2026

    • Table Consumption Share of RNAi for Therapeutic by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of siRNA

    • Figure Market Size and Growth Rate of miRNA

    • Figure Market Size and Growth Rate of shRNA

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of RNAi for Therapeutic by Different End-Users from 2014 to 2026

    • Table Consumption Share of RNAi for Therapeutic by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Cancer

    • Figure Market Size and Growth Rate of Cardiovascular

    • Figure Market Size and Growth Rate of HBV

    • Figure Market Size and Growth Rate of Others

    • Table Global RNAi for Therapeutic Production by Major Regions

    • Table Global RNAi for Therapeutic Production Share by Major Regions

    • Table Global RNAi for Therapeutic Consumption by Major Regions

    • Table Global RNAi for Therapeutic Consumption Share by Major Regions

    • Table North America RNAi for Therapeutic Production, Import, Consumption and Export Analysis

    • Table Europe RNAi for Therapeutic Production, Import, Consumption and Export Analysis

    • Table Asia Pacific RNAi for Therapeutic Production, Import, Consumption and Export Analysis

    • Table LAMEA RNAi for Therapeutic Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in RNAi for Therapeutic Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in RNAi for Therapeutic Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in RNAi for Therapeutic Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in RNAi for Therapeutic Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America RNAi for Therapeutic Consumption by Major Countries from 2014 to 2026

    • Table North America RNAi for Therapeutic Consumption Share by Major Countries from 2014 to 2026

    • Figure North America RNAi for Therapeutic Consumption Share by Major Countries in 2014

    • Figure North America RNAi for Therapeutic Consumption Share by Major Countries in 2018

    • Figure North America RNAi for Therapeutic Consumption Share by Major Countries in 2026

    • Figure United States RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Table Europe RNAi for Therapeutic Consumption by Types from 2014 to 2026

    • Table Europe RNAi for Therapeutic Consumption Share by Types from 2014 to 2026

    • Table Europe RNAi for Therapeutic Consumption by End-Users from 2014 to 2026

    • Table Europe RNAi for Therapeutic Consumption Share by End-Users from 2014 to 2026

    • Table Europe RNAi for Therapeutic Consumption by Major Countries from 2014 to 2026

    • Table Europe RNAi for Therapeutic Consumption Share by Major Countries from 2014 to 2026

    • Figure Germany RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure UK RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure France RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Spain RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Portugal RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Denmark RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific RNAi for Therapeutic Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific RNAi for Therapeutic Consumption Share by Major Countries from 2014 to 2026

    • Figure China RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure India RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa RNAi for Therapeutic Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa RNAi for Therapeutic Consumption Share by Major Countries from 2014 to 2026

    • Figure GCC Countries RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Countries RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure North Africa Countries RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Countries RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Countries RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mirna Therapeutics

    • Figure Sales and Growth Rate Analysis of Mirna Therapeutics

    • Figure Revenue and Market Share Analysis of Mirna Therapeutics

    • Table Product and Service Introduction of Mirna Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arrowhead

    • Figure Sales and Growth Rate Analysis of Arrowhead

    • Figure Revenue and Market Share Analysis of Arrowhead

    • Table Product and Service Introduction of Arrowhead

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of miRagen Therapeutics

    • Figure Sales and Growth Rate Analysis of miRagen Therapeutics

    • Figure Revenue and Market Share Analysis of miRagen Therapeutics

    • Table Product and Service Introduction of miRagen Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Quark Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Quark Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Quark Pharmaceuticals

    • Table Product and Service Introduction of Quark Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dicerna Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Dicerna Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Dicerna Pharmaceuticals

    • Table Product and Service Introduction of Dicerna Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alnylam Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Alnylam Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Alnylam Pharmaceuticals

    • Table Product and Service Introduction of Alnylam Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gradalis

    • Figure Sales and Growth Rate Analysis of Gradalis

    • Figure Revenue and Market Share Analysis of Gradalis

    • Table Product and Service Introduction of Gradalis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sirnaomics

    • Figure Sales and Growth Rate Analysis of Sirnaomics

    • Figure Revenue and Market Share Analysis of Sirnaomics

    • Table Product and Service Introduction of Sirnaomics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of RXi Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of RXi Pharmaceuticals

    • Figure Revenue and Market Share Analysis of RXi Pharmaceuticals

    • Table Product and Service Introduction of RXi Pharmaceuticals

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.